Skip to content
The Policy VaultThe Policy Vault

Alinia — CareFirst (Caremark)

Human fascioliasis (Fasciola hepatica)

Initial criteria

  • For Alinia for Oral Suspension, patient age ≥ 1 year
  • For Alinia Tablets, patient age ≥ 12 years
  • Alinia for Oral Suspension and Alinia Tablets have not been shown to be effective for the treatment of diarrhea caused by Cryptosporidium parvum in HIV-infected or immunodeficient patients